Petrovax continues its successful efforts as part of the National Immunisation Schedule

NPO Petrovax Pharm announces the successful completion of government contracts under the National Immunisation Schedule. In 2014, a total of 13.5 m doses of the Grippol® Plus influenza vaccine and 3.4 m doses of Prevenar 13, a 13-valent pneumococcal conjugate vaccine, were shipped to regions of Russia.

Petrovax Pharm boasts many years of experience in manufacturing and supplying immunobiological medicines for the National Immunisation Schedule. Over the past six years, the company has been acting as the supplier of the Grippol® Plus vaccine for children and pregnant women across Russia. In 2014 (for the first time ever), Petrovax achieved the shortest delivery time in supplying Prevenar 13 to all Russian regions to treat infants.

Both medicines are manufactured under the international GMP standards at Petrovax Pharm's production facility in the Moscow Region, and are available in disposable syringes.

In 2015, Petrovax continues with its strategy for immunobiologicals and plans to produce over 15 m doses of Grippol® Plus and over 5 m doses of Prevenar 13.

Previous news

Petrovax completed scheduled pneumococcal vaccine supplies